Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
Abstract: Enterovirus 71 (EV-A71) is one of the predominant etiological agents of hand, foot and mouth disease (HMFD), which can cause severe central nervous system infections in young children. There is no clinically approved vaccine or antiviral agent against HFMD. The SP40 peptide, derived from t...
| Main Authors: | Masomian, Malihe *, Lalani, S.*, Poh, Chit Laa * |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI
2021
|
| Subjects: | |
| Online Access: | http://eprints.sunway.edu.my/1883/ http://eprints.sunway.edu.my/1883/1/Malihe%20Masomian%20Molecular%20Docking%20Molecules-26-06576.pdf |
Similar Items
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)
by: Lalani, S.*, et al.
Published: (2021)
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)
by: Lalani, S.*, et al.
Published: (2020)
Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice
by: Lalani, Salima, et al.
Published: (2021)
by: Lalani, Salima, et al.
Published: (2021)
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)
Characterization of plaque variants and the involvement of Quasi-Species in a population of EV-A71
by: Mandary, M. B. *, et al.
Published: (2020)
by: Mandary, M. B. *, et al.
Published: (2020)
Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)
by: Poh, Chit Laa *, et al.
Published: (2019)
T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)
Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)
Insights into innate and adaptive immune responses in vaccine development against EV-A71
by: Lim, Hui Xuan *, et al.
Published: (2019)
by: Lim, Hui Xuan *, et al.
Published: (2019)
Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)
Development of live attenuated Enterovirus 71 vaccine strains that confer protection against lethal challenge in mice
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
by: Yee, Isabel Pin Tsin *, et al.
Published: (2019)
Pluripotent human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy
by: Yap, May Shin *, et al.
Published: (2016)
by: Yap, May Shin *, et al.
Published: (2016)
A decade of sustained selection pressure on two surface sites of the VP1 protein of Enterovirus A71 suggests that immune evasion may be an indirect driver for virulence
by: Roberts, Ryan, et al.
Published: (2019)
by: Roberts, Ryan, et al.
Published: (2019)
Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)
by: Poh, Chit Laa *
Published: (2018)
Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)
by: Ooi, Mong How, et al.
Published: (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)
by: Solomon, Tom, et al.
Published: (2010)
High-titred neutralizing antibodies to human enterovirus 71 preferentially bind to the N-terminal portion of the capsid protein VP1
by: Tan, Cheng Siang, et al.
Published: (2007)
by: Tan, Cheng Siang, et al.
Published: (2007)
Inhibition of Enterovirus 71 (EV-71 infections by a novel
antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)
by: Tan, Chee Wah, et al.
Published: (2012)
RSAD2 and AIM2 modulateCV-A16 and EV-A71 replication in neuronal cells in different ways that may be associated with their 5′ non-translated regions
by: David, Perera
Published: (2017)
by: David, Perera
Published: (2017)
Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)
by: Chew, Miaw Fang *, et al.
Published: (2017)
Development of next generation Streptococcus pneumoniae vaccines conferring broad protection
by: Masomian, Malihe *, et al.
Published: (2020)
by: Masomian, Malihe *, et al.
Published: (2020)
Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
Novel Multiplex Oligonucleotide-Conjugated Bead Suspension Array for Rapid Identification of Enterovirus 71 Subgenogroups
by: Wu, Y., et al.
Published: (2011)
by: Wu, Y., et al.
Published: (2011)
A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)
by: Tan, Le Van, et al.
Published: (2015)
Enhancement of tetravalent immune responses to highly conserved epitopes of a dengue peptide vaccine conjugated to polystyrene nanoparticles
by: Chan, Yanqi, et al.
Published: (2020)
by: Chan, Yanqi, et al.
Published: (2020)
Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease
by: Ong, Kien Chai, et al.
Published: (2010)
by: Ong, Kien Chai, et al.
Published: (2010)
Development of a multiplex polymerase chain reaction assay for simultaneous identification of human enterovirus 71 and coxsackievirus A16.
by: Thao, Nguyen Thi Thanh, et al.
Published: (2010)
by: Thao, Nguyen Thi Thanh, et al.
Published: (2010)
The conserved molecular determinants of virulence in
dengue virus
by: Zuleeza A,, et al.
Published: (2019)
by: Zuleeza A,, et al.
Published: (2019)
Recent advances in delivery of veterinary DNA vaccines against avian pathogens
by: Jazayeri, S. D. *, et al.
Published: (2019)
by: Jazayeri, S. D. *, et al.
Published: (2019)
Development of universal influenza vaccines targeting conserved viral proteins
by: Jazayeri, S. D. *, et al.
Published: (2019)
by: Jazayeri, S. D. *, et al.
Published: (2019)
Enterovirus 71 encephalomyelitis and Japanese encephalitis can be distinguished by topographic distribution of inflammation and specific intraneuronal detection of viral antigen and RNA
by: Wong, K.T., et al.
Published: (2012)
by: Wong, K.T., et al.
Published: (2012)
Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)
by: Reginald, Kavita*, et al.
Published: (2017)
Structural vaccinology for viral vaccine design
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)
Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-associated hand, foot, and mouth disease in Sibu, Sarawak.
by: Cardosa, Mary Jane, et al.
Published: (1999)
by: Cardosa, Mary Jane, et al.
Published: (1999)
Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)
by: Anasir, M. I. *, et al.
Published: (2020)
Validation and utilization of an internally controlled multiplex Real-time RT-PCR assay for simultaneous detection of enteroviruses and enterovirus A71 associated with hand foot and mouth disease
by: Thanh, Tran Tan, et al.
Published: (2015)
by: Thanh, Tran Tan, et al.
Published: (2015)
Identification and selection of immunodominant B and T cell epitopes for dengue multi-epitope-based vaccine
by: Lim, Hui Xuan *, et al.
Published: (2021)
by: Lim, Hui Xuan *, et al.
Published: (2021)
Understanding the differentiation, expansion, recruitment and suppressive activities of myeloid-derived suppressor cells in cancers
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
Development of multi-epitope peptide-based vaccines against SARS-CoV-2
by: Lim, Hui Xuan *, et al.
Published: (2020)
by: Lim, Hui Xuan *, et al.
Published: (2020)
Similar Items
-
Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021) -
Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020) -
Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020) -
Molecular mechanism of L-SP40 peptide and in vivo efficacy against EV-A71 in neonatal mice
by: Lalani, Salima, et al.
Published: (2021) -
Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)